Abbreviations used in this paper: ΔΨ~m~, mitochondrial membrane potential; AEQ, aequorin; IP3, inositol 1,4,5 trisphosphate; ROS, reactive oxygen species.

Introduction
============

PKC comprises a family of serine/threonine protein kinases, which participate in transducing intracellularly a wide number of extracellular signals ([@bib30]). They have been shown to participate in signaling events as diverse as cell proliferation, apoptosis, smooth muscle contraction, and secretion ([@bib13]; [@bib55]). Up to 12 distinct family members have been discovered in mammalian cells. They have been subdivided into three classes: (1) the classical or conventional PKCs (α, βI, βII, and γ) activated by Ca^2+^ and diacylglycerol; (2) the new or novel PKCs (δ, ɛ, η, and θ) activated by diacylglycerol but Ca^2+^ independent; and (3) the atypical PKCs (λ and ζ), which are Ca^2+^ and diacylglycerol insensitive ([@bib36]).

On the one hand, Ca^2+^ is a crucial activator of some PKC isoforms; on the other hand, PKC-dependent phosphorylation reactions have been shown to modify the spatio-temporal pattern of cellular Ca^2+^ responses. Indeed, PKCs were shown to differentially decode high and low frequency Ca^2+^ spiking ([@bib38]) and to modulate Ca^2+^ release from the ER evoked by agonist stimulation ([@bib33]). Thus, they appear to be an important part of the molecular machinery underlying the wide complexity of Ca^2+^ signaling ([@bib43]; [@bib11]; [@bib4]). As the site of action, much remains to be explored. Indeed, PKCs were shown to associate to cellular domains and organelles playing a crucial role in generating and decoding Ca^2+^ signals, such as the plasma membrane, the ER, the Golgi apparatus, and the mitochondria ([@bib19]; [@bib56]; [@bib40]).

In this contribution, we took advantage of intracellularly targeted Ca^2+^ probes (the aequorin chimeras) and a panel of PKC-GFP fusion proteins to explore the effects of the various PKC isoforms on the Ca^2+^ signals occurring in different cellular domains. Specifically, we constructed a panel of PKC-GFP chimeras that allow the molecular repertoire of these effectors to be altered. The chimeras include the α, β, δ, ɛ, and ζ isoforms ([@bib9]). For measuring Ca^2+^ concentration, we used aequorin-based recombinant probes ([@bib44]; [@bib6]; [@bib32]; [@bib41]) that can be cotransfected with the protein of interest, thus providing an accurate monitoring of Ca^2+^ signaling in the transfected subset of cells, and probes that are specifically targeted to a defined subcellular compartment, thus providing a complete analysis of intracellular Ca^2+^ homeostasis. In our work, we analyzed the effects of the various isoforms on organelle Ca^2+^ handling, with special focus on mitochondria. These organelles act as an important "decoding station," where Ca^2+^ signals can exert effects as diverse as stimulation of aerobic metabolism ([@bib24]) and release of proapoptotic factors to the cytoplasm ([@bib27]).

By this means, we observed that the overexpression of different PKC isoforms induces specific alterations of cellular Ca^2+^ homeostasis. In particular, we observed an effect of some isoforms on mitochondrial Ca^2+^ responses. Then, we addressed the mechanisms that allow this fine modulation of mitochondrial Ca^2+^ homeostasis and analyzed some possible targets of PKC action, such as the mitochondrial membrane potential (ΔΨ~m~; i.e., the driving force for the Ca^2+^ uptake into the organelle), the production of reactive oxygen species (ROS), and the three-dimensional structure of the organelle. Finally, we obtained evidence for the involvement of the β isoform of PKC in the yet poorly understood phenomenon of desensitization of mitochondrial Ca^2+^ responses ([@bib28]; [@bib8]).

Results
=======

Different effects of PKC isoforms on mitochondrial Ca^2+^ signaling
-------------------------------------------------------------------

The initial goal of our work was to evaluate whether or not the various PKC isoforms could differently affect Ca^2+^ handling in mitochondria, which is an important site for decoding cellular Ca^2+^ signals. For this purpose, a defined PKC isoform was overexpressed through the panel of PKC-GFP chimeras developed in the laboratory, and mitochondrial Ca^2+^ homeostasis was monitored through a cotransfected mitochondrially targeted aequorin (AEQ) probe, mtAEQ. Specifically, HeLa cells were either cotransfected with the PKC-GFP chimera of interest and mtAEQ (PKC overexpressing) or transfected with mtAEQ alone (control). After transfection and reconstitution of the photoprotein (see Materials and methods for details), the coverslip with the transfected cells was transferred to the luminometer chamber and data were collected. In all cases, the mitochondrial Ca^2+^ response to histamine, an agonist acting on Gq-coupled receptor and causing the production of inositol 1,4,5 trisphosphate (IP3), was investigated ([Fig. 1](#fig1){ref-type="fig"}). Both in control and PKC-transfected cells, histamine stimulation caused a large, rapid rise in mitochondrial Ca^2+^ concentration (\[Ca^2+^\]~m~) that returned to almost basal levels in ∼1 min. The effect of overexpressed PKC isoforms on this \[Ca^2+^\] response was different. In cells overexpressing PKCɛ, the histamine-dependent \[Ca^2+^\]~m~ rise was almost unchanged (peak amplitude: 87 ± 14 μM \[PKCɛ\] vs. 91 ± 4 μM \[control\]; *n* = 18, P \> 0.05), indicating that the alteration of mitochondrial Ca^2+^ responses is not a general feature of all PKCs. In contrast, in PKCα-, β-, and δ-transfected cells, the \[Ca^2+^\]~m~ increases evoked by stimulation with histamine were significantly smaller than in controls (peak amplitude: 29 ± 5 μM \[PKCα\], 34 ± 4 μM \[PKCβ\], and 43 ± 8 μM \[PKCδ\]; *n* = 11, P \< 0.05). On the contrary, in cells overexpressing PKCζ, the \[Ca^2+^\] rise was markedly larger (peak amplitude: 109 ± 9 μM; *n* = 15, P \< 0.05).

![**Mitochondrial Ca** ^2**+**^ **homeostasis in control and PKC-overexpressing HeLa cells.** Parallel batches of HeLa cells were either cotransfected with mtAEQ and a PKC-GFP chimera including the indicated PKC isoform or transfected with mtAEQ alone (Control). 36 h after transfection, the measurement of AEQ luminescence was performed and calibrated into \[Ca^2+^\] values as described in Materials and methods. Where indicated, the cells were challenged with 100 μM histamine. In this and in the following aequorin experiments, the traces are representative of at least 10 from 3 independent experiments, which gave similar results.](200311061f1){#fig1}

To rule out the possibility that we were observing spurious effects due to major overexpression of active kinases (and thus a global perturbation of cellular functions), we aimed at confirming these observations in cells expressing only endogenous kinases by using isoform-specific PKC inhibitors. The expectation was to observe an effect opposite to that caused by the recombinant overexpression of the kinase. In these experiments, mtAEQ-expressing HeLa cells were treated 16 h before the Ca^2+^ measurements with 10 μM Ro-32-0432 ([@bib5]), 5 μM hispidin ([@bib18]), or 50 μM PKCζ pseudosubstrate inhibitor myristoylated ([@bib50]) to inhibit endogenous PKCα, β, or ζ, respectively ([Fig. 2](#fig2){ref-type="fig"}). \[Ca^2+^\]~m~ responses to histamine stimulations were evaluated as in [Fig. 1](#fig1){ref-type="fig"}. The results obtained well match those obtained by overexpressing the different PKC isoforms. Indeed, the inhibition of PKCα and β caused a significant increase of the \[Ca^2+^\]~m~ rise evoked by histamine (peak amplitude: 152 ± 14 μM \[PKCα\] and 107 ± 9 μM \[PKCβ\]; *n* = 7, P \< 0.05). Interestingly, the increase caused by the inhibitors appears larger in the case of inhibition of PKCα than of PKCβ both in absolute terms and as a percent (77 vs. 21% increase, respectively). These are fully specular results to the overexpression experiments of PKCα and PKCβ, indicating a more pronounced inhibitory effect of PKCα. Vice versa the inhibition of PKCζ drastically reduced the \[Ca^2+^\]~m~ rise (peak amplitude: 66 ± 4 μM; *n* = 11, P \< 0.05). The inhibition of the PKCδ (with Rottlerin) was not, in our hands, informative, as the prolonged exposure to the inhibitor not only almost abolished both cytosolic and mitochondrial Ca^2+^ responses but also was associated to high cell mortality.

![**Effects of PKCα, β, and ζ inhibitors on mitochondrial Ca** ^2**+**^ **homeostasis.** HeLa cells were transfected with the mtAEQ chimera. 16 h before the aequorin measurement (performed 36 h after transfection), the cells were treated with 10 μM Ro-32-0432 (PKCα inhibitor), 5 μM hispidin (PKCβ inhibitor), or 50 μM PKCζ pseudosubstrate inhibitor myristoylated (PKCζ inhibitor), as labeled. Where indicated, the cells were challenged with 100 μM histamine. All other conditions were as in [Fig. 1](#fig1){ref-type="fig"}. Traces from control and inhibitor-treated cells are displayed in gray or black, respectively.](200311061f2){#fig2}

The analysis of intracellular calcium stores and of cytosolic Ca^2+^ responses indicates a specific mitochondrial effect for some PKC isoform
---------------------------------------------------------------------------------------------------------------------------------------------

We investigated whether or not the \[Ca^2+^\]~m~ changes were paralleled by alterations of cytosolic Ca^2+^ signals. Indeed, the mitochondrial Ca^2+^ response usually follows and amplifies the agonist-dependent cytosolic rise. In the experiment shown in [Fig. 3](#fig3){ref-type="fig"} A, HeLa cells, either coexpressing the PKC chimera of interest and cytosolic aequorin (PKC overexpressing) or expressing only cytosolic aequorin (control) ([@bib6]), were challenged with histamine. As expected based on mitochondrial results, there is no difference in the cytosolic Ca^2+^ response between control and PKCɛ-overexpressing cells (peak amplitude: 2.6 ± 0.1 μM \[PKCɛ\] vs. 2.6 ± 0.1 μM \[control\]; *n* = 18, P \> 0.05). A significant reduction of the response was observed in the PKCα-overexpressing cells (peak amplitude: 1.8 ± 0.1 μM; *n* = 12, P \< 0.05). Surprisingly, in contrast with the mitochondrial results, in the cytosolic compartment there is only a small reduction in PKCβ- and PKCδ-overexpressing cells (peak amplitude: 2.2 ± 0.1 μM; *n* = 17, P \< 0.05 for PKCβ and 2.3 ± 0.2 μM; *n* = 15, P \> 0.05 for PKCδ) and no difference was detected in PKCζ-overexpressing cells (peak amplitude: 2.6 ± 0.2 μM; *n* = 15, P \> 0.05).

![**Cytosolic Ca** ^2**+**^ **homeostasis in control and PKC-overexpressing HeLa cells.** (A) Aequorin measurements: parallel batches of HeLa cells were either cotransfected with cytAEQ and a PKC-GFP chimera including the indicated PKC isoform or transfected with the cytAEQ alone (Control). All other conditions were as in [Fig. 1](#fig1){ref-type="fig"}. Where indicated, the cells were challenged with 100 μM histamine. (B) Relationship between cytosolic and mitochondrial Ca^2+^ responses: parallel batches of HeLa cells were transfected with either the cytAEQ or the mtAEQ chimera. All other conditions were as in [Fig. 1](#fig1){ref-type="fig"}. To reduce the \[Ca^2+^\]~c~ and \[Ca^2+^\]~m~ responses, the Ca^2+^ stores were partially depleted by preincubating the cells in KRB/EGTA for different periods (as indicated) before challenging them with 100 μM histamine. \[Ca^2+^\]~c~ and \[Ca^2+^\]~m~ responses are expressed as a percentage of the peak amplitude (compare with control, non-EGTA--pretreated cells). The inset highlights the condition in which the reduction of the \[Ca^2+^\]~c~ response is the same of that observed on PKC overexpression. (C) Fura-2 measurements: HeLa cells transfected with PKCβ-GFP or PKCδ-GFP (top) and loaded with fura-2 were stimulated with 100 μM histamine. The kinetic behavior of the \[Ca^2+^\]~c~ response (bottom) is presented as a 340:380 nm ratio.](200311061f3){#fig3}

Given the nonlinear dependence of mitochondrial Ca^2+^ accumulation on \[Ca^2+^\]~c~, we could not rule out, in principle, that the small reduction of the \[Ca^2+^\]~c~ peak of PKCβ- and PKCδ-expressing cells accounted for the large drop of the \[Ca^2+^\]~m~ response. To verify this possibility, we performed a specific series of experiments, aimed at directly assessing the correlation between the \[Ca^2+^\]~c~ and \[Ca^2+^\]~m~ responses. In these experiments, \[Ca^2+^\]~c~ was gradually reduced by incubating the cells in EGTA-containing, Ca^2+^-free KRB (KRB/EGTA) for variable time lengths before challenging them with histamine. This process caused a progressively larger decrease in the histamine-induced \[Ca^2+^\]~c~ peak, from 8% (after 5 min in KRB/EGTA) to 19% (after 50 min), and in the \[Ca^2+^\]~m~ peak, from 19% (after 5 min in KRB/EGTA) to 38% (after 50 min). It is apparent that for an ∼15% reduction of the \[Ca^2+^\]~c~ peak (i.e., slightly larger than that observed in PKCβ- and PKCδ-overexpressing cells), the decrease of the \[Ca^2+^\]~m~ peak was ∼24% (compared with an ∼63 and 53% reduction in PKCβ- and PKCδ-overexpressing cells, respectively). We verified if the PKC isoforms could alter the kinetics of the \[Ca^2+^\]~c~ rise (an effect that could be overlooked by the low temporal resolution of the aequorin measurements). For this purpose, we performed single cell fura-2 imaging studies, comparing the \[Ca^2+^\]~c~ responses of PKCβ-GFP-- and PKCδ-GFP--transfected cells (identified by the GFP moiety) with those of nontransfected cells. Representative cells and traces are shown in [Fig. 3](#fig3){ref-type="fig"} C; in this and similar experiments, no difference could be detected between PKCβ (or PKCδ)-transfected and control cells in either the kinetics or the peak value of the histamine-induced \[Ca^2+^\]~c~ rise. Overall, these experiments indicate that no major feature of cytosolic Ca^2+^ signaling is significantly affected by the overexpression of these PKC isoforms; thus, the major reduction of the \[Ca^2+^\]~c~ responses must be ascribed to a direct effect on mitochondrial Ca^2+^ homeostasis.

To confirm the latter conclusion, we also investigated the effect of PKC overexpression on the agonist-sensitive Ca^2+^ stores. Although the key parameter for mitochondrial Ca^2+^ uptake (the \[Ca^2+^\]~c~ transient) was unaffected, we wanted to exclude the possibility that ER loading (or its discharge properties) was affected by the activity of the PKC isoforms, an effect that could have a greater impact on \[Ca^2+^\]~m~ than \[Ca^2+^\]~c~. Indeed, in a recent paper, by altering ER Ca^2+^ levels through overexpression of SERCA (sarco-ER Ca^2+^ ATPase) or plasma membrane Ca^2+^ ATPase, [@bib7] showed that mitochondrial Ca^2+^ responses correlate with the state of filling of the Ca^2+^ stores and the rate and extent of Ca^2+^ release rather than with the \[Ca^2+^\] rise detected in the bulk cytosol ([@bib7]).

Thus, we monitored the \[Ca^2+^\] of agonist-sensitive Ca^2+^ stores, using the aequorin chimeras targeted to the endoplasmic reticulum (erAEQ; [@bib32]) or to the Golgi apparatus (GoAEQ; [@bib41]). For this purpose, HeLa cells were either cotransfected with the PKC chimera of interest and erAEQ (or GoAEQ; PKC-overexpressing) or transfected with erAEQ (or GoAEQ) alone (control; see Materials and methods). [Figs. 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"} show the calibrated \[Ca^2+^\] values in the two compartments. To obtain reliable quantitative estimates of the \[Ca^2+^\] in the lumen of these two organelles, their \[Ca^2+^\] needs to be decreased during both the reconstitution of aequorin with coelenterazine and the subsequent initial phase of perfusion with KRB/EGTA in the luminometer (see Materials and methods). Under those conditions, the \[Ca^2+^\] was \<10 μM in both organelles. When the \[Ca^2+^\] in the perfusion medium was switched to 1 mM, the \[Ca^2+^\] in the lumen of the two compartments gradually increased. The \[Ca^2+^\] in the lumen of the two compartments, in control cells, reached a plateau value of 419 ± 10 μM (*n* = 39) in the ER and 228 ± 8 μM (*n* = 27) in the Golgi apparatus. In PKC-transfected cells, Ca^2+^ was reaccumulated in the organelles with a similar time course, and comparable steady-state values were attained in both compartments (ER: 392 ± 7 μM \[PKCɛ\], 417 ± 8 μM \[PKCα\], 399 ± 6 μM \[PKCβ\], 386 ± 10 μM \[PKCδ\], and 424 ± 8 μM \[PKCζ\]; *n* = 10, P \> 0.05; Golgi apparatus: 227 ± 7 μM \[PKCɛ\], 245 ± 6 μM \[PKCα\], 246 ± 7 μM \[PKCβ\], 257 ± 10 μM \[PKCδ\], and 217 ± 6 μM \[PKCζ\]; *n* = 6, P \> 0.05). To have a complete picture of the Ca^2+^ handling properties of Ca^2+^ stores, the basal Ca^2+^ leak from the ER was also investigated. In these experiments, after aequorin reconstitution, the ER was refilled with Ca^2+^ as described in the previous paragraph. Then, the SERCA inhibitor 2,5-di-(tert-butyl)-1,4-benzohydroquinone was added to the perfusion medium to initiate passive Ca^2+^ efflux from the ER. No difference in the leak rate between PKCs transfected and control cells was observed (unpublished data).

![**Ca** ^2**+**^ **homeostasis in the ER lumen of control and PKC-overexpressing HeLa cells.** Parallel batches of HeLa cells were either cotransfected with erAEQ and a PKC-GFP chimera including the indicated PKC isoform or transfected with erAEQ alone (control). 36 h after transfection, the Ca^2+^ stores were depleted of Ca^2+^ to optimize aequorin reconstitution as detailed in the text. After reconstitution, the cells were transferred to the luminometer chamber, and the ER store was refilled by switching the perfusion medium from KRB/EGTA to KRB/Ca^2+^. Where indicated, the cells were perfused with 1 mM CaCl~2~ and challenged with 100 μM histamine.](200311061f4){#fig4}

![**Ca** ^2**+**^ **homeostasis in the lumen of the Golgi apparatus of control and PKC-overexpressing HeLa cells.** Parallel batches of HeLa cells were either cotransfected with GoAEQ and a PKC-GFP chimera including the indicated PKC isoform or transfected with GoAEQ alone (Control). Aequorin reconstitution, experimental layout, and data display are as in [Fig. 4](#fig4){ref-type="fig"}. Where indicated, the cells were perfused with 1 mM CaCl~2~ and challenged with 100 μM histamine.](200311061f5){#fig5}

Together, the aforementioned data indicate that the differences previously observed in cellular Ca^2+^ homeostasis, induced by overexpression of the different PKC isoforms, are not due to changes in the filling state of the intracellular Ca^2+^ stores. These results are particularly interesting (and partially unexpected) in the case of PKCα-overexpressing cells, in which a very marked reduction of mitochondrial and cytosolic responses to agonists had been observed.

We investigated the release phase (i.e., the \[Ca^2+^\]~ER~ decrease occurring after agonist stimulation; [Fig. 4](#fig4){ref-type="fig"}). The rapid \[Ca^2+^\]~ER~ drop after histamine addition was larger (73 ± 6 μM \[PKCα\] vs. 115 ±11 μM \[control\]; *n* = 9, P \< 0.05) in control cells compared with PKCα-transfected cells, indicating a substantially reduced release through the IP3-gated channels. These data are fully consistent with the cytosolic and mitochondria reduction of Ca^2+^ responses and suggest a direct, inhibitory effect on one of the components of the signaling cascade from the plasma membrane receptor to the Ca^2+^ release channels (i.e., from IP3 production to the activity of the IP3-gated channels).

On the contrary, with the other PKC isoforms, little or no effect on Ca^2+^ release was observed: a small reduction in ER Ca^2+^ release in PKCβ-transfected cells (85 ± 6 μM; *n* = 9, P \> 0.05) and no difference with all others isoforms (139 ± 10 μM \[PKCδ\], 129 ± 13 \[PKCɛ\], and 118 ± 8 μM \[PKCζ\]; *n* = 9, P \> 0.05). Similar results were obtained from the analysis of the Golgi store. Also in this case, the only significant effect was a smaller Ca^2+^ release in PKCα-overexpressing cells ([Fig.5](#fig5){ref-type="fig"}).

Together, these data show that although PKCα globally affects cellular Ca^2+^ signaling, the other isoforms (i.e., the β, δ, and ζ) appear to modulate mitochondrial Ca^2+^ responses without significantly altering cellular Ca^2+^ homeostasis, most likely acting directly on this organelle.

Mitochondrial membrane potential, ROS production, and organelle morphology in PKC-expressing cells
--------------------------------------------------------------------------------------------------

Next, the nature of this mitochondrial effect was investigated. At first, we verified the occurrence of ΔΨ~m~ changes in PKC-GFP--transfected and control cells. Using the ΔΨ~m~-sensitive dyes (TMRM and JC-1), no statistically significant difference was detected between control and PKC-expressing cells (identified by the GFP tag), although a small number of cells with detectable ΔΨ~m~ decreases was observed upon PKCα and β transfection. To be able to detect small changes, we decided to measure free radical production in mitochondria using the ROS-sensitive fluorescent probe CM-H~2~DCFDA. ROS (ROS: O~2~ ^−^\*, H~2~O~2~, OH\*) are generated from chemical reactions of molecular oxygen with the enzymes and coenzymes of the respiratory chain. This process is physiological and continuous ([@bib52]), and mitochondrial ROS production was shown to strictly depend in a nonlinear way on ΔΨ~m~. Indeed, even small ΔΨ~m~ decreases cause a large (measurable) inhibition of mitochondrial ROS production, whereas ΔΨ~m~ increases cause a significant stimulation of ROS production ([@bib26]).

Thus, we performed single cell analysis of mitochondrial ROS production in PKC-overexpressing cells. Mitochondrial contribution was estimated by evaluating the effect of the collapse of ΔΨ~m~ with FCCP on total ROS production, as detailed in Materials and methods. Although a great variability was observed between individual cells, \>80% cells showed a mitochondrial ROS production ranging between 10 and 40% of total cellular production. No significant difference was detected upon overexpression of PKCɛ and ζ. Conversely, mitochondrial ROS production appeared greatly decreased upon overexpression of PKCα and β (∼50 and 25% of cells, respectively, compared with \<10% of control cells, had a mitochondrial ROS production \<10%). Upon overexpression of PKCδ, mitochondrial ROS production was increased (∼45% of PKCδ-expressing cells, compared with \<10% of control cells, had a mitochondrial ROS production \>50%). Although a ΔΨ~m~ change could not be directly shown with TMRM, these data suggest that, in the case of PKCβ, a small reduction in the driving force for Ca^2+^ accumulation may occur, which could be in part responsible for the reduction of mitochondrial Ca^2+^ accumulation.

Finally, we wished to rule out the possibility that the alteration of mitochondrial Ca^2+^ responses was a consequence of a major structural perturbation of the organelle (that could cause the loss of the ER--mitochondria contacts, essential for the large and prompt uptake of Ca^2+^ by mitochondria). Mitochondrial structure was evaluated by labeling the organelle with TMRM (that could be used in association with the PKC-GFPs) and visualizing it with a confocal microscope. [Fig. 6](#fig6){ref-type="fig"} shows the mitochondrial fluorescence image obtained from cells overexpressing the different PKC-GFP chimeras. It is apparent that in all cases PKC overexpression caused no obvious alteration in mitochondrial morphology, despite the occurrence of occasional structural rearrangements both in transfected and nontransfected cells.

![**Analysis of mitochondrial structure in PKC-overexpressing cells.** HeLa cells were transfected with the PKC-GFP chimera including the indicated PKC isoform and loaded with 10 nM TMRM. Transfected cells were identified by visualizing GFP fluorescence (right), and mitochondrial structure was visualized with TMRM (left) as specified in Materials and methods. The field of cells is representative of \>50 observations from at least 5 independent experiments.](200311061f6){#fig6}

PKCβ is involved in the desensitization of mitochondrial Ca^2+^ uptake
----------------------------------------------------------------------

A phenomenon that attracted much interest in the study of mitochondrial Ca^2+^ signaling is the drastic reduction in amplitude occurring when two consecutive stimuli are applied. Several factors contribute to this experimental observation: (a) the second stimulation with the same agonist evokes a smaller cytosolic response (due to receptor desensitization); this response has a greater effect on mitochondrial Ca^2+^ accumulation, as shown in the experiment of [Fig. 3](#fig3){ref-type="fig"} B. (b) When aequorin is used for measuring \[Ca^2+^\]~m~, the higher probe consumption (and depletion) in the mitochondrial regions close to the ER may lead to an artifactual underestimation of the following response ([@bib47]; [@bib16]). However, evidence has been obtained that this reduction, at least in part, represents a true desensitization of the mitochondrial Ca^2+^ uptake machinery that has important physiological consequences (e.g., an inhibition of events that depend on mitochondrial Ca^2+^ accumulation, such as insulin secretion; [@bib28]). The mechanism of this inhibitory effects is still unknown, and we investigated the possibility that the PKC isoforms, which are activated upon agonist stimulation and specifically reduce the capacity of mitochondria of accumulating Ca^2+^, such as PKCβ, could be involved.

The working hypothesis was that if PKCβ has a role in desensitizing mitochondrial Ca^2+^ uptake, its inhibition during the first histamine stimulation should lead to an increase of the \[Ca^2+^\]~m~ rise observed during the second agonist challenge. On the contrary, the second \[Ca^2+^\]~c~ rise should not be affected. Thus, the cells were treated with the specific inhibitor of PKCβ hispidin (applied 1 min before the first application of histamine, maintained throughout agonist stimulation, and washed away). The results are shown in [Fig. 7](#fig7){ref-type="fig"} B. The short treatment with the PKCβ inhibitor does not change the first response (consistent with the low PKCβ expression in HeLa cells; [@bib10]). On the contrary, it markedly increases the \[Ca^2+^\]~m~ peak evoked by the second histamine stimulation (62 ± 14 μM vs. 38 ± 8 μM; *n* = 12, P \< 0.05), whereas no differences were observed in the cytosolic response (2.3 ± 0.6 μM vs. 2.3 ± 0.9 μM; *n* = 9, P \> 0.05; [Fig. 7](#fig7){ref-type="fig"} D). This potentiation of the second response is due to a PKCβ-dependent desensitization (i.e., a "long-term memory" of the first stimulation) and not to a direct effect of the short treatment with the PKC inhibitor. Indeed, the application of the PKC inhibitor by itself (e.g., not in coincidence with a first histamine stimulation) does not modify the response to histamine applied 10 min after the pulse with the inhibitor ([Fig. 7](#fig7){ref-type="fig"} C, inset).

![**Effect of PKC**β **inhibitor hispidin on the reduction of mitochondrial Ca^2^** ^+^ **accumulation occurring upon repeated agonist stimulation.** Mitochondrial (A and C) and cytosolic (B and D) \[Ca^2+^\] was monitored in PKCβ-overexpressing cells as in [Fig. 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}, respectively. Where indicated, the cells were treated with 100 μM histamine and 5 μM hispidin (PKCβ inhibitor).](200311061f7){#fig7}

Given the confounding effect of the heterogeneous consumption of the aequorin probe during the first stimulation, we wished to confirm these results using a radically different probe that is endowed with higher affinity (and thus could underestimate the \[Ca^2+^\]~m~ peak and small reductions in \[Ca^2+^\]~m~ responses) but is not consumed during repetitive agonist stimulations. We used a mitochondrially targeted Camgaroo (mtCamgaroo-2), an insertional mutant of GFP sensitive to Ca^2+^ ([@bib20]). HeLa cells were transfected with mtCamgaroo-2, analyzed with an imaging system based on a highly sensitive camera, and treated with the double stimulation protocol used for the aequorin experiments. With this mitochondrial Ca^2+^ probe, the second histamine response is reduced to ∼18% (compared with the first one) in control cells (*n* = 18, P \< 0.05), whereas no difference in the mitochondrial response was detectable in the presence of the PKCβ inhibitor hispidin (*n* = 16, P \> 0.05).

Discussion
==========

PKCs comprise a closely related set of enzymes activated by Ca^2+^ and/or diacylglycerol (i.e., second messengers produced upon engagement of Gq-coupled plasma membrane receptors; [@bib30]). Molecular diversity within the PKC protein family (underlying different molecular targets and mechanisms of activation) and/or specific tissue or subcellular distribution of the isozymes make these Ca^2+^ transducers a versatile toolkit, which allows stimulation of different receptors to convert into very diverse cellular effects ([@bib14]; [@bib55]; [@bib39]; [@bib51]). For example, PKCα and δ have been demonstrated to have diametrically opposite effects on the process of apoptosis ([@bib49]; [@bib29]).

However, PKC participates in Ca^2+^ signaling not only by activating downstream effectors (enzymes, channels, and transcription factors; [@bib3]; [@bib23]; [@bib34]) but also by shaping the spatio-temporal properties of the Ca^2+^ signal itself, highlighting a complex interplay between the ion second messenger and its decoding machinery. First, the changes in intracellular Ca^2+^ concentration and the timing of PKC activation were shown to exhibit different kinetics. [@bib38] showed that activation of the Ca^2+^-sensitive PKCγ required the displacement of an inhibitor pseudosubstrate; thus, PKC activation (and ensuing cellular response) lagged behind agonist stimulation. This observation implies that repetitive Ca^2+^ spikes may be necessary for maximal PKC recruitment, and agonist specific spiking frequencies (that can have results varying from sustained PKC recruitment to no mobilization at all) can be differentially decoded inside the cell ([@bib38]). Moreover, in an elegant paper, [@bib31] show how, in pancreatic β cells, the short-lived Ca^2+^ signal is transduced via PKC activation into long-term phosphorylation of substrate with important implications for the control of important phenomena such as insulin secretion.

Second, the Ca^2+^ response itself can be modified by a previous activation of PKC. This notion is supported by the presence of consensus sequences for PKC phosphorylation in important proteins related with Ca^2+^ homeostasis such as the IP3 receptor ([@bib57]; [@bib37]), the Ca^2+^ ATPase of the plasma membrane ([@bib59]), and several agonist receptors ([@bib17]). This modulatory effect was recently demonstrated by [@bib33], who showed that PKC inhibition (through the use of a wide-spectrum blocker that guaranteed the inhibition of all isozymes) drastically reduced the agonist-dependent Ca^2+^ responses in HeLa cells. The data clearly indicated a major role for PKC in tuning the intensity of Ca^2+^ signals through an effect on the release kinetics of the agonist-sensitive Ca^2+^ store.

In this work, we have investigated two main aspects. First, we have separately analyzed the effect of various PKC isoforms belonging to different subgroups of the protein family on the cellular Ca^2+^ signaling patterns. Second, we took advantage of organelle-specific Ca^2+^ probes (the targeted chimeras of the Ca^2+^-sensitive photoprotein aequorin) to investigate if some PKC isoform can exert a specific effect on the different Ca^2+^ pools, thus altering the cross talk between the various reservoirs of this signaling ion. We devoted special attention to mitochondria, which is an important decoding checkpoint of Ca^2+^ signals ([@bib15]; [@bib48]). Indeed, Ca^2+^ increases in the mitochondrial matrix, which are triggered by agonist stimulation but also by apoptotic agents such as ceramide, can induce, within the organelle, effects as diverse as stimulation of organelle metabolism ([@bib21]; [@bib24]) and morphological alterations, with the ensuing release of caspase cofactors and the induction of apoptotic cell death ([@bib53]; [@bib42]). Moreover, mitochondrial Ca^2+^ uptake influences the properties of cytoplasmic Ca^2+^ increases by either forming a firewall that prevents or delays the spread of Ca^2+^ waves ([@bib54]) or rapidly clearing Ca^2+^ at ER--mitochondria contacts, reducing the (positive or negative) feedback activity of Ca^2+^ on the ER release channels ([@bib22]). Finally, it was recently proposed that Ca^2+^ release from mitochondria (through the activation of the mitochondrial Na^+^-Ca^2+^ exchanger) induces a Ca^2+^ rise in presynaptic endings, which contributes to posttetanic potentiation of neurotransmitters release ([@bib58]). For these reasons, the specific modulation of the capacity of mitochondria to accumulate or release Ca^2+^ (without affecting the global Ca^2+^ responses of the cell) can greatly increase the flexibility of this signaling pathway.

The detailed analysis of the different PKC isoforms (obtained by overexpressing a specific isozyme or inhibiting it specifically in wild-type cells, two complementary approaches that provided a coherent picture) revealed defined, differentiated roles for the various members of the protein family. A preliminary observation is that subunits belonging to the same subgroup (e.g., α and β, and δ and ɛ) had very different effects, indicating that PKC-dependent modulation of Ca^2+^ signaling is based on the recruitment of highly specific substrates or second messenger production patterns. In the case of PKCɛ, no alteration was observed in either the steady-state \[Ca^2+^\] levels of resting cells or in the changes occurring upon cell stimulation in any of the investigated compartments (ER, Golgi apparatus, cytosol, and mitochondria), indicating that the modulation of cellular Ca^2+^ signals is not a general property shared by all PKC isoforms. In the case of PKCα, a major reduction was observed in the amplitude of Ca^2+^ responses induced by histamine stimulation. Although the resting levels in the ER and Golgi Ca^2+^ stores were the same of control cells, the drop in luminal \[Ca^2+^\] was much smaller, and consequently the Ca^2+^ rises occurring in the cytosol and in the mitochondria were significantly reduced. We have not investigated where this desensitization of global Ca^2+^ signals occurs (i.e., at the level of receptor, G protein, phospholipase C, or IP3-receptor); however, we note that these results closely match those of [@bib33], suggesting that the increase of Ca^2+^ responses that they observe upon application of wide-spectrum PKC inhibitors ([@bib33]) most likely reflects the inhibition of PKCα.

However, the most surprising results were obtained with PKCβ, δ, and ζ. Indeed, when the activity of these isoforms was enhanced (by overexpression) or inhibited, the effect was almost exclusively on mitochondrial Ca^2+^ uptake. Indeed, although no significant alteration was detected in ER Ca^2+^ release (and in the amplitude and kinetic properties of the \[Ca^2+^\]~c~ rise), mitochondrial \[Ca^2+^\] transients were reduced by PKC β and δ and increased by PKC ζ. Unfortunately, it is very difficult to verify which is the molecular site of this regulation, as the most plausible targets are still undefined at the molecular level. Indeed, the Ca^2+^ transport system of the inner mitochondrial membrane, characterized in terms of biochemical properties (an electrogenic uniporter for accumulation, an exchanger with Na^+^ or H^+^ for release), are still unknown, and consequently no information is available also on regulatory proteins that can interact with them and influence their activity. We have investigated whether or not the alteration of mitochondrial Ca^2+^ responses could be indirect, i.e., affecting either the three-dimensional structure of the organelle (and thus the possibility of establishing close contacts with the ER Ca^2+^ store \[[@bib47]\] that allow fast Ca^2+^ accumulation into mitochondria) or the driving force for the uptake of the cation (e.g., affecting the expression or activity of uncoupling proteins). On the former aspect, using TMRM to label the organelle, we observed no alteration of the three-dimensional mitochondrial network on expression of any of the PKC isoforms used in our work. As to the driving force, mitochondrial membrane potential was directly measured with ΔΨ~m~-sensitive dyes and indirectly assessed through ROS production. No increase was detected with the ζ isoform, nor decrease with the δ, whereas a probably modest decrease in ΔΨ~m~ was detected in cells overexpressing the β isoforms. Thus, an indirect effect through ΔΨ~m~ can be excluded in the former case, whereas it is possible that the sharp decrease of \[Ca^2+^\]~m~ responses induced by PKCβ is in part mediated by a reduction of the driving force for Ca^2+^ accumulation. Conversely, the primary effect of the PKCζ, and most likely of PKCδ, appears to be on mitochondrial Ca^2+^ uptake, and its clarification awaits the molecular definition of this important process.

Finally, we investigated if this regulatory mechanism could be responsible for the well-known phenomenon of mitochondrial desensitization to repetitive agonist stimulation described in cell systems as diverse as pancreatic β-cells ([@bib35]; [@bib1]; [@bib25]) and skeletal myotubes (Challet et al., 2001; whereas in HeLa cells it was observed only in some experimental conditions \[[@bib12]; [@bib16]\]). In brief, a second stimulation with an agonist causing a \[Ca^2+^\]~c~ rise induces a drastically reduced \[Ca^2+^\]~m~ transient that cannot be fully accounted for by receptor desensitization but must be ascribed to a reduced Ca^2+^ uptake capacity of the organelle. This phenomenon was shown to have important physiological implications, as it correlates in pancreatic β cells with a major reduction in insulin secretion ([@bib28]), but no information on the possible mechanism was available. In this contribution, we provide evidence that mitochondrial Ca^2+^ desensitization can be ascribed to PKC isoforms that are activated by stimulation of receptors coupled to the production of diacylglycerol and IP3 (and thus cause a Ca^2+^ signal) and induce a reduction in the capacity of mitochondria to rapidly accumulate Ca^2+^. A regulatory mechanism based on PKC-dependent phosphorylation can also explain the fact that in permeabilized cells such a desensitization was not observed ([@bib45]), as in this case cytosolic proteins, such as PKCs, are lost.

In conclusion, the results of this paper reveal specific roles of the various PKC isoforms in shaping the Ca^2+^ signals evoked by agonist stimulation in different Ca^2+^ pools and cellular domains. In particular, the activity of defined PKC isoforms was shown to modulate mitochondrial responses, while leaving global Ca^2+^ signals unaffected. Thus, mitochondria emerge as a "sink" of Ca^2+^ released from the ER or entering through plasma membrane channels endowed with unique properties. On the one hand, they participate in decoding Ca^2+^-linked agonist stimulations (through intra- and extramitochondrial effects); on the other hand, they can vary their response based on the convergence of PKC-mediated (and possibly other) signaling pathways. Although future work will address the molecular targets of this regulatory mechanism, these results may already highlight novel pharmacological routes for specifically modifying Ca^2+^-dependent cellular dysfunctions that occur in a variety of genetic and acquired human disorders.

Materials and methods
=====================

Cell culture and transfection
-----------------------------

HeLa cells were grown in DME supplemented with 10% FCS in 75 cm^2^ Falcon flasks. For aequorin measurements, the cells were seeded before transfection onto 13-mm glass coverslips and allowed to grow to 50% confluence. At this stage, transfection with 4 μg of plasmid DNA (control cells: 3 μg mtGFP + 1 μg AEQ; PKC-overexpressing cells: 3 μg PKC-GFP chimera of interest + 1 μg AEQ) was performed as described previously ([@bib46]) and aequorin measurements were performed 36 h after transfection. For ΔΨ~m~, ROS production, and fura-2 measurements, the cells (seeded onto 24-mm coverslips) were transfected with 8 μg PKC-GFP plasmid. For single cells \[Ca^2+^\]~m~ measurements, HeLa cells were seeded onto 24-mm coverslips and transfected with 8 μg mtCamgaroo-2 ([@bib20]).

Aequorin measurements
---------------------

For cytosolic aequorin (cytAEQ) and mitochondrial aequorin (mtAEQ) measurements, the coverslip with the cells was incubated with 5 μM coelenterazine for 1--2 h in DME supplemented with 1% FCS and transferred to the perfusion chamber. For reconstituting with high efficiency the aequorin chimeras targeted to the Golgi apparatus and the ER (GoAEQ and erAEQ, respectively), the luminal \[Ca^2+^\] of these compartments must first be reduced. This result was obtained by incubating the cells for 1 h at 4°C in KRB (Krebs-Ringer modified buffer: 125 mM NaCl, 5 mM KCl, 1 mM Na~3~PO~4,~ 1 mM MgSO~4,~ 5.5 mM glucose, and 20 mM Hepes, pH 7.4, at 37°C) supplemented with 5 μM ionomycin and 600 μM EGTA in the presence of 5 μM coelenterazine n. After this incubation, the cells were extensively washed with KRB supplemented with 2% BSA and 1 mM EGTA. All aequorin measurements were performed in KRB supplemented with 1 mM CaCl~2~ (KRB/Ca^2+^). Agonists and other drugs were added to the same medium, as specified in the figure legends. The experiments were terminated by lysing the cells with 100 μM digitonin in a hypotonic Ca^2+^-rich solution (10 mM CaCl~2~ in H~2~O), thus discharging the remaining aequorin pool. The light signal was collected and calibrated into \[Ca^2+^\] values as described previously ([@bib6]; [@bib2]). All the results are expressed as means ± SEM.

Measurements of ΔΨ~m~, ROS production, and microscopic analysis of mitochondrial structure
------------------------------------------------------------------------------------------

ROS production in control and PKC-transfected cells was measured with the ROS-sensitive fluorescent probe 5- (and 6)-chloromethyl-2\',7\'-dichlorohydrofluoresceindiacetate (CM-H~2~DCFDA). The acetate group of CM-H~2~DCFDA is hydrolyzed by esterases inside the cell and it is trapped as a nonfluorescent probe (CM-H~2~DCF). Then, ROS increases its fluorescence. Cells were incubated with 2 μM CM-H~2~DCFDA for 20 min and washed with KRB/Ca^2+^. The green emission of CM-DCF was recorded at 520 nm. Acquisitions were made every 1 s (exposure time 100--200 ms). After a few minutes, when the rate of free radical production was constant, 300 nM FCCP was added to depolarize mitochondria (drastically reducing mitochondrial ROS production), and the measurements were continued for a few other minutes. The difference between the rates of ROS production before and after FCCP addition reflected the mitochondrial contribution to cellular ROS production (expressed as a percentage of total production). Images were recorded using a digital imaging system based on a fluorescence microscope (model Axiovert 200; Carl Zeiss MicroImaging, Inc.) equipped with a back-illuminated CCD camera (Roper Scientific), excitation and emission filterwheels (Sutter Instrument Company), and piezoelectric motoring of the z stage (Physik Instrumente; GmbH & Co.). The data were acquired and processed using the MetaFluor analyzing program (Universal Imaging Corp.). ΔΨ~m~ was measured using 10 nM TMRM on a confocal microscope (model LSM 510; Carl Zeiss MicroImaging, Inc.). The signal was collected as total emission \>570 nm. To distinguish control from PKC-GFP--transfected cells, green emission was collected in the range \>505--\<535 nm. Mitochondrial structure of control and PKC-transfected cells was studied on a confocal microscope after loading 10 nM TMRM. Red and green signals (visualizing mitochondrial structure and identifying transfected cells, respectively) were collected as described in the previous paragraph.

Fura-2 measurements
-------------------

The coverslip with PKC-transfected HeLa cells was incubated with 5 μM fura-2 (added to DME + 1% FCS) at 37°C for 30 min. After a brief wash with KRB/Ca^2+^, they were placed in an open Leyden chamber on the thermostated stage of an inverted microscope (model Axiovert; Carl Zeiss MicroImaging, Inc.) equipped with a Sutter filterwheel and 340/380 excitation filters. The fluorescence data were collected with a back-illuminated camera (Princeton Instruments) and expressed as emission ratios using the Metafluor software (Universal Imaging Corp.). Within the microscope field, transfected and untransfected cells were identified before carrying out the fura-2 monitoring by revealing the fluorescence of mtGFP, cotransfected with the PKC isoform of interest.

\[Ca^2+^\] measurements with mtCamgaroo-2
-----------------------------------------

The coverslip with the mtCamgaroo-2--transfected cells were placed in an open Leyden chamber on the thermostated stage of an inverted microscope equipped with a Sutter filterwheel. The fluorescence data were collected with a back-illuminated camera using the Metafluor software. The time of illumination was reduced to a minimum (50 ms) and at least 1 s between two successive illuminations were allowed to avoid the well-known phenomenon of photoconversion of the probe into a form almost completely insensitive to Ca^2+^ changes, as reported by [@bib16].
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